Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell death—to survive treatment. Instead of dying, these “persister cells” leverage this sublethal signal to regrow. Because the mechanism is non-genetic, it appears much earlier than typical resistance mutations. Targeting this enzyme could help stop tumors from returning.
source https://www.sciencedaily.com/releases/2025/12/251210092022.htm
"This was not opportunistic. It was precision." — How North Korean hackers
used Microsoft Teams and Slack to compromise Windows PCs with an elaborate
ploy
-
Malware ploys from bad actors are getting more elaborate, as axios
maintainer Jason Saayman explains how the registry's hijacking was weeks in
the making a...
15 hours ago
No comments:
Post a Comment